CRSP Competitors & Alternatives
Compare Crispr Therapeutics AG with similar stocks in the same industry
Biotechnology
CRSP
Main Stock$55.79
Tradestie Score
40
Market Cap
$6.02B
Revenue Growth
10.4%
Analyst Upside
+56.9%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$114.79
|
$6.38B | - | 65 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$21.52
|
$6.03B | - | 46 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$206.68
|
$5.92B | - | 58 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.99
|
$5.80B | 20.8 | 36 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$358.24
|
$5.20B | 46.5 | 52 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$61.16
|
$4.94B | - | 45 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$69.30
|
$4.93B | - | 56 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$86.34
|
$4.84B | - | 54 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More CRSP Analysis
Data updated: Sep 06, 2026 | Industry: Biotechnology (SIC 2836)
239 stocks in this industry